Free Trial
Memorial Day Savings! Save $100 on MarketBeat All Access
Claim Your Discount
Claim MarketBeat All Access Sale Promotion

Constellium (CSTM) Financials

Constellium logo
$32.09 -0.04 (-0.11%)
Closing price 05/21/2026 03:59 PM Eastern
Extended Trading
$32.12 +0.02 (+0.07%)
As of 05:24 AM Eastern
Extended trading is trading that happens on electronic markets outside of regular trading hours. This is a fair market value extended hours price provided by Massive. Learn more.
Compare
Annual Income Statements for Constellium

Annual Income Statements for Constellium

This table shows Constellium's income and expenses over time, based on annual financial data. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Income / (Loss) Attributable to Common Shareholders		 -600 -4.21 -37 220 77 -26 291 308 152 56 273
Consolidated Net Income / (Loss)		 -600 -4.21 -37 217 72 -21 297 315 157 60 275
Net Income / (Loss) Continuing Operations		 -600 -4.21 -37 217 72 -21 297 315 157 60 275
Total Pre-Tax Income 		-635 68 59 254 92 -42 359 150 232 135 408
Total Operating Income		 -463 259 322 287 312 153 548 343 386 272 474
Total Gross Profit		 489 563 667 616 676 599 752 963 1,055 938 1,187
Total Revenue		 5,431 4,990 6,291 6,508 6,629 5,965 6,963 8,532 7,826 7,335 8,449
Operating Revenue		 5,431 4,990 6,291 6,508 6,629 5,965 6,963 8,532 7,826 7,335 8,449
Total Cost of Revenue		 5,110 4,427 5,624 5,892 5,954 5,367 6,211 7,569 6,771 6,397 7,262
Operating Cost of Revenue		 5,110 4,427 5,624 5,892 5,954 5,367 6,211 7,569 6,771 6,397 7,262
Total Operating Expenses		 809 304 345 328 364 446 204 620 669 666 713
Selling, General & Admin Expense		 266 266 297 283 310 290 292 284 317 313 332
Research & Development Expense		 38 33 43 46 54 48 44 46 52 49 51
Depreciation Expense		 - - - - - - - 290 300 304 330
Total Other Income / (Expense), net		 -142 -190 -263 -33 -220 -194 -189 -193 -154 -137 -66
Interest Expense		 - 198 312 208 194 - - 103 111 111 109
Other Income / (Expense), net		 -142 22 84 175 -26 - - -90 - - 43
Income Tax Expense		 -35 73 96 37 20 -21 62 -165 75 75 133
Net Income / (Loss) Attributable to Noncontrolling Interest		 - 0.00 0.00 -2.29 -5.61 -4.89 -5.66 7.00 5.00 4.00 2.00
Basic Earnings per Share		 - ($0.04) ($0.28) $1.40 $0.43 ($0.15) $1.82 $2.14 $1.04 $0.38 $1.95
Weighted Average Basic Shares Outstanding		 - - 134.51M 134.76M 136.86M 138.74M 141.00M 144.30M 146.82M 143.52M 135.07M
Diluted Earnings per Share		 - ($0.04) ($0.28) $1.37 $0.41 ($0.15) $1.75 $2.10 $1.03 $0.38 $1.92
Weighted Average Diluted Shares Outstanding		 - - 134.51M 138.15M 142.65M 138.74M 147.17M 144.30M 146.82M 143.52M 135.07M
Weighted Average Basic & Diluted Shares Outstanding		 - - 134.51M 136.00M 137.87M 139.96M 141.68M 144.30M 146.82M 143.52M 135.07M

Quarterly Income Statements for Constellium

This table shows Constellium's income and expenses over time, based on quarterly financial data. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Income / (Loss) Attributable to Common Shareholders		 21 76 7.00 -48 37 36 88 112 199
Consolidated Net Income / (Loss)		 22 77 8.00 -47 38 36 88 113 196
Net Income / (Loss) Continuing Operations		 22 77 8.00 -47 38 36 88 113 196
Total Pre-Tax Income 		30 104 19 -18 62 56 126 164 272
Total Operating Income		 75 116 52 29 94 81 133 166 227
Total Gross Profit		 245 280 205 208 263 263 314 347 420
Total Revenue		 1,880 1,932 1,802 1,721 1,979 2,103 2,166 2,201 2,461
Operating Revenue		 1,880 1,932 1,802 1,721 1,979 2,103 2,166 2,201 2,461
Total Cost of Revenue		 1,635 1,652 1,597 1,513 1,716 1,840 1,852 1,854 2,041
Operating Cost of Revenue		 1,635 1,652 1,597 1,513 1,716 1,840 1,852 1,854 2,041
Total Operating Expenses		 170 164 153 179 169 182 181 181 193
Selling, General & Admin Expense		 80 75 66 92 78 88 85 81 97
Research & Development Expense		 15 13 11 10 13 12 12 14 13
Depreciation Expense		 75 76 76 77 78 82 84 86 83
Total Other Income / (Expense), net		 -45 -12 -33 -47 -32 -25 -7.00 -2.00 45
Interest Expense		 27 25 31 28 27 29 27 26 28
Other Income / (Expense), net		 -18 13 -2.00 - -5.00 4.00 20 24 73
Income Tax Expense		 8.00 27 11 29 24 20 38 51 76
Net Income / (Loss) Attributable to Noncontrolling Interest		 1.00 1.00 1.00 1.00 1.00 0.00 0.00 1.00 -3.00
Basic Earnings per Share		 $0.14 $0.52 $0.05 ($0.33) $0.26 $0.25 $0.63 $0.81 $1.47
Weighted Average Basic Shares Outstanding		 - - - 143.52M 142.92M 139.54M 137.80M 135.07M 136.15M
Diluted Earnings per Share		 $0.14 $0.51 $0.05 ($0.32) $0.26 $0.25 $0.62 $0.79 $1.42
Weighted Average Diluted Shares Outstanding		 - - - 143.52M 142.92M 139.54M 137.80M 135.07M 136.15M
Weighted Average Basic & Diluted Shares Outstanding		 - - - 143.52M 142.92M 139.54M 137.80M 135.07M 136.15M

Annual Cash Flow Statements for Constellium

This table details how cash moves in and out of Constellium's business through operations, investing, and financing, using annual figures. All values are USD millions unless otherwise specified.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Net Change in Cash & Equivalents		 -827 -139 -85 -122 20 316 -338 19 39 -73 -35
Net Cash From Operating Activities		 -600 93 192 76 502 408 404 365 432 301 489
Net Cash From Continuing Operating Activities		 -600 93 192 76 502 408 404 365 432 301 489
Net Income / (Loss) Continuing Operations		 -600 -4.21 -37 217 72 -21 297 315 157 60 275
Consolidated Net Income / (Loss)		 -600 -4.21 -37 217 72 -21 297 315 157 60 275
Depreciation Expense		 - 163 205 225 287 316 302 290 300 304 330
Non-Cash Adjustments To Reconcile Net Income		 - 203 360 66 155 186 238 -82 53 73 53
Changes in Operating Assets and Liabilities, net		 - -269 -336 -434 -12 -73 -432 -158 -78 -136 -169
Net Cash From Investing Activities		 4.35 -384 -351 -104 -396 -215 -250 -196 -216 -313 -309
Net Cash From Continuing Investing Activities		 4.35 -384 -351 -104 -396 -215 -250 -196 -216 -313 -309
Purchase of Property, Plant & Equipment		 - - - - - - - -289 -366 -413 -330
Acquisitions		 - 22 0.00 0.00 -93 - - 0.00 0.00 3.00 0.00
Divestitures		 4.35 - - - - - - 0.00 51 0.00 -1.00
Other Investing Activities, net		 - -27 -22 -16 -1.12 0.00 0.00 93 99 97 22
Net Cash From Financing Activities		 -231 153 73 -94 -85 123 -492 -150 -177 -61 -215
Net Cash From Continuing Financing Activities		 -231 153 73 -94 -85 123 -492 -150 -177 -61 -215
Repayment of Debt		 -229 -156 -1,873 -1.14 -117 -255 -1,191 -130 -155 -640 -87
Repurchase of Common Equity		 - - - - - - - 0.00 0.00 -79 -115
Payment of Dividends		 - -2.10 0.00 0.00 -4.49 0.00 -2.26 -2.00 -3.00 -5.00 -7.00
Issuance of Debt		 - 322 1,765 -77 127 442 800 0.00 0.00 671 0.00
Other Financing Activities, net		 -2.17 -12 -130 -16 -91 -64 -100 -18 -19 -8.00 -6.00

Quarterly Cash Flow Statements for Constellium

This table details how cash moves in and out of Constellium's business through operations, investing, and financing, using quarterly figures. All values are USD millions unless otherwise specified.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
Net Change in Cash & Equivalents		 -23 36 -67 -19 -27 6.00 -11 -3.00 25
Net Cash From Operating Activities		 37 138 65 61 58 114 99 218 73
Net Cash From Continuing Operating Activities		 37 138 65 61 58 114 99 218 73
Net Income / (Loss) Continuing Operations		 22 77 8.00 -47 38 36 88 113 196
Consolidated Net Income / (Loss)		 22 77 8.00 -47 38 36 88 113 196
Depreciation Expense		 75 76 76 77 78 82 84 86 83
Non-Cash Adjustments To Reconcile Net Income		 15 20 -23 61 24 -4.00 7.00 26 30
Changes in Operating Assets and Liabilities, net		 -75 -35 4.00 -30 -82 - -80 -7.00 -236
Net Cash From Investing Activities		 -50 -61 -77 -125 -59 -72 -69 -109 -68
Net Cash From Continuing Investing Activities		 -50 -61 -77 -125 -59 -72 -69 -109 -68
Purchase of Property, Plant & Equipment		 -74 -84 -104 -151 -69 -77 -75 -109 -72
Other Investing Activities, net		 24 23 24 26 10 5.00 6.00 1.00 4.00
Net Cash From Financing Activities		 -10 -41 -55 45 -26 -36 -41 -112 20
Net Cash From Continuing Financing Activities		 -10 -41 -55 45 -26 -36 -41 -112 20
Repayment of Debt		 0.00 -4.00 -706 70 -7.00 2.00 -11 -71 54
Repurchase of Common Equity		 -7.00 -32 -21 -19 -15 -35 -25 -40 -28
Payment of Dividends		 -1.00 -2.00 -1.00 -1.00 -2.00 -2.00 -3.00 - -4.00
Other Financing Activities, net		 -2.00 -3.00 -1.00 -2.00 -2.00 -1.00 -2.00 -1.00 -2.00

Annual Balance Sheets for Constellium

This table presents Constellium's assets and liabilities at the end of each period, using annual balance sheet data. All values are USD millions unless otherwise specified.

Metric 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Total Assets		 3,984 4,458 4,465 4,696 5,044 5,233 5,286 4,933 4,734 5,354
Total Current Assets		 1,483 1,682 1,649 1,515 1,791 3,198 787 1,992 1,834 2,322
Cash & Equivalents		 365 323 188 206 536 166 178 223 141 120
Accounts Receivable		 373 503 672 532 496 773 577 531 486 723
Inventories, net		 622 772 755 752 711 2,193 - 1,197 1,181 1,407
Other Current Assets		 - - - - - - - 41 26 72
Plant, Property, & Equipment, net		 1,554 1,822 1,907 2,307 2,328 2,205 0.00 2,422 2,408 2,585
Total Noncurrent Assets		 947 954 909 873 925 835 929 519 492 447
Noncurrent Note & Lease Receivables		 - - - - - - - 34 36 31
Goodwill		 481 484 483 511 509 510 511 41 46 47
Intangible Assets		 83 82 80 79 75 66 58 104 97 88
Noncurrent Deferred & Refundable Income Taxes		 265 197 260 275 236 183 290 337 311 270
Other Noncurrent Operating Assets		 101 190 85 7.86 105 76 55 3.00 2.00 11
Total Liabilities & Shareholders' Equity		 3,984 4,458 4,465 4,696 5,044 5,233 5,286 4,933 4,734 5,354
Total Liabilities		 4,584 4,841 4,595 4,791 5,167 4,904 4,481 4,191 4,007 4,383
Total Current Liabilities		 1,075 1,333 1,201 1,428 1,327 1,940 1,822 1,556 1,446 1,798
Short-Term Debt		 113 127 - 226 112 292 202 41 39 39
Accounts Payable		 883 1,117 1,139 1,121 1,106 1,558 1,592 1,411 1,309 1,674
Current Deferred & Payable Income Tax Liabilities		 - 13 9.16 16 24 38 - 22 18 18
Current Employee Benefit Liabilities		 - - - - - - - 24 22 24
Other Current Liabilities		 80 76 53 65 84 51 - 58 58 43
Total Noncurrent Liabilities		 3,495 3,508 3,395 3,363 3,841 2,964 2,660 2,635 2,561 2,585
Long-Term Debt		 2,484 2,428 2,462 2,424 2,808 2,118 2,056 1,888 1,879 1,905
Noncurrent Deferred & Payable Income Tax Liabilities		 32 30 25 27 12 16 30 35 39 70
Noncurrent Employee Benefit Liabilities		 773 798 698 752 811 678 431 431 375 338
Other Noncurrent Operating Liabilities		 206 252 209 160 209 153 142 281 268 272
Commitments & Contingencies		 - - - - - - - 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 -600 -383 -130 -95 -123 329 804 742 727 971
Total Preferred & Common Equity		 -609 -393 -140 -95 -264 310 782 718 706 952
Total Common Equity		 -609 -393 -140 -579 -654 -165 333 718 706 952
Common Stock		 2.10 3.60 3.43 3.37 3.66 3.40 3.21 517 678 697
Retained Earnings		 -782 -901 - -582 - - - - 93 354
Treasury Stock		 - - - - - - - - -51 -153
Accumulated Other Comprehensive Income / (Loss)		 - - - - - - - 0.00 -14 54
Noncontrolling Interest		 9.47 9.61 9.16 12 17 19 22 24 21 19

Quarterly Balance Sheets for Constellium

This table presents Constellium's assets and liabilities at the end of each period, using quarterly balance sheet data. All values are USD millions unless otherwise specified.

Metric Q1 2025 Q2 2025 Q3 2025 Q1 2026
Period end date 3/31/2025 6/30/2025 9/30/2025 3/31/2026
Total Assets		 5,168 5,368 5,375 5,845
Total Current Assets		 2,236 2,312 2,353 2,951
Cash & Equivalents		 118 133 122 143
Accounts Receivable		 818 805 819 1,005
Inventories, net		 1,278 1,328 1,366 1,671
Other Current Assets		 22 46 46 132
Plant, Property, & Equipment, net		 2,456 2,564 2,572 2,524
Total Noncurrent Assets		 476 492 450 370
Noncurrent Note & Lease Receivables		 38 40 38 33
Goodwill		 46 47 47 47
Intangible Assets		 94 93 90 84
Noncurrent Deferred & Refundable Income Taxes		 294 291 257 202
Other Noncurrent Operating Assets		 4.00 21 18 4.00
Total Liabilities & Shareholders' Equity		 5,168 5,368 5,375 5,845
Total Liabilities		 4,403 4,569 4,512 4,713
Total Current Liabilities		 1,808 1,873 1,842 2,118
Short-Term Debt		 35 54 38 35
Accounts Payable		 1,665 1,717 1,711 1,973
Current Deferred & Payable Income Tax Liabilities		 17 18 21 20
Current Employee Benefit Liabilities		 23 24 24 23
Other Current Liabilities		 68 60 48 67
Total Noncurrent Liabilities		 2,595 2,696 2,670 2,595
Long-Term Debt		 1,908 1,972 1,974 1,938
Noncurrent Deferred & Payable Income Tax Liabilities		 48 64 54 66
Noncurrent Employee Benefit Liabilities		 377 394 385 329
Other Noncurrent Operating Liabilities		 262 266 257 262
Commitments & Contingencies		 0.00 0.00 0.00 0.00
Total Equity & Noncontrolling Interests		 765 799 863 1,132
Total Preferred & Common Equity		 745 780 845 1,119
Total Common Equity		 745 780 845 1,119
Common Stock		 517 517 517 708
Retained Earnings		 - - - 529
Treasury Stock		 - - - -157
Accumulated Other Comprehensive Income / (Loss)		 -1.00 26 21 39
Noncontrolling Interest		 20 19 18 13

Annual Metrics And Ratios for Constellium

This table displays calculated financial ratios and metrics derived from Constellium's official financial filings.

Metric 2015 2016 2017 2018 2019 2020 2021 2022 2023 2024 2025
Period end date 12/31/2015 12/31/2016 12/31/2017 12/31/2018 12/31/2019 12/31/2020 12/31/2021 12/31/2022 12/31/2023 12/31/2024 12/31/2025
Growth Metrics		 - - - - - - - - - - -
Revenue Growth		 0.00% -8.12% 26.08% 3.45% 1.87% -10.02% 16.73% 22.54% -8.27% -6.27% 15.19%
EBITDA Growth		 0.00% 173.35% 37.73% 12.50% -16.63% -18.20% 81.20% -36.12% 18.42% -14.46% 47.05%
EBIT Growth		 0.00% 146.41% 44.55% 13.88% -38.11% -46.64% 258.74% -53.81% 35.57% -28.28% 90.07%
NOPAT Growth		 0.00% 95.08% -1,178.89% 220.72% -0.96% -56.10% 323.56% 59.09% -63.74% -53.72% 164.28%
Net Income Growth		 0.00% 99.30% -784.95% 683.96% -66.97% -128.91% 1,527.88% 6.23% -50.16% -61.78% 358.33%
EPS Growth		 0.00% 0.00% -600.00% 589.29% -70.07% -136.59% 1,266.67% 20.00% -50.95% -63.11% 405.26%
Operating Cash Flow Growth		 0.00% 115.44% 107.61% -60.70% 564.11% -18.67% -0.97% -9.67% 18.36% -30.32% 62.46%
Free Cash Flow Firm Growth		 0.00% 0.00% 69.57% 78.89% 130.44% 624.07% -492.79% 685.85% -158.71% 102.23% -56.10%
Invested Capital Growth		 0.00% 0.00% 17.22% 19.47% 10.14% -4.67% 58.66% -120.56% 439.00% 2.29% 11.62%
Revenue Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 6.02%
EBITDA Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 28.72%
EBIT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 53.41%
NOPAT Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 86.31%
Net Income Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 139.13%
EPS Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 137.04%
Operating Cash Flow Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 47.29%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 1.53%
Profitability Metrics		 - - - - - - - - - - -
Gross Margin		 9.00% 11.28% 10.60% 9.46% 10.19% 10.03% 10.79% 11.29% 13.48% 12.79% 14.05%
EBITDA Margin		 -11.14% 8.90% 9.72% 10.57% 8.65% 7.86% 12.21% 6.36% 8.22% 7.50% 10.02%
Operating Margin		 -8.52% 5.19% 5.12% 4.41% 4.71% 2.56% 7.87% 4.02% 4.93% 3.71% 5.61%
EBIT Margin		 -11.14% 5.63% 6.45% 7.11% 4.32% 2.56% 7.87% 2.97% 4.38% 3.35% 6.12%
Profit (Net Income) Margin		 -11.04% -0.08% -0.59% 3.34% 1.08% -0.35% 4.26% 3.69% 2.01% 0.82% 3.25%
Tax Burden Percent		 94.52% -6.15% -63.27% 85.59% 78.05% 50.00% 82.65% 210.00% 67.67% 44.44% 67.40%
Interest Burden Percent		 104.85% 24.34% 14.50% 54.95% 32.16% -27.20% 65.50% 59.29% 67.64% 54.88% 78.92%
Effective Tax Rate		 0.00% 106.15% 163.27% 14.41% 21.95% 0.00% 17.35% -110.00% 32.33% 55.56% 32.60%
Return on Invested Capital (ROIC)		 0.00% -2.12% -12.46% 12.70% 10.99% 4.71% 15.82% 51.64% 30.27% 4.88% 12.06%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% -1.00% -4.63% 11.40% 3.62% -0.66% 10.15% 2.69% -85.91% 1.39% 9.59%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 3.52% 20.03% -97.36% -74.59% 14.27% 272.12% 3.93% -9.97% 3.29% 20.33%
Return on Equity (ROE)		 0.00% 1.40% 7.58% -84.67% -63.60% 18.99% 287.93% 55.56% 20.30% 8.17% 32.39%
Cash Return on Invested Capital (CROIC)		 0.00% -202.12% -28.31% -5.05% 1.34% 9.49% -29.54% 0.00% -118.83% 2.62% 1.08%
Operating Return on Assets (OROA)		 0.00% 7.05% 9.62% 10.36% 6.25% 3.14% 10.66% 4.81% 6.71% 5.09% 10.25%
Return on Assets (ROA)		 0.00% -0.11% -0.88% 4.87% 1.57% -0.43% 5.77% 5.99% 3.07% 1.24% 5.45%
Return on Common Equity (ROCE)		 0.00% 1.43% 7.72% -87.76% -202.38% 106.97% -1,144.63% 8.21% 13.79% 7.92% 31.63%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 0.69% 9.48% -155.74% -75.29% 7.87% 95.62% 40.28% 21.87% 8.50% 0.00%
Net Operating Profit after Tax (NOPAT)		 -324 -16 -204 246 244 107 453 720 261 121 319
NOPAT Margin		 -5.97% -0.32% -3.24% 3.78% 3.67% 1.79% 6.50% 8.44% 3.34% 1.65% 3.78%
Net Nonoperating Expense Percent (NNEP)		 0.00% -1.11% -7.83% 1.30% 7.37% 5.37% 5.66% 48.95% 116.19% 3.50% 2.47%
Return On Investment Capital (ROIC_SIMPLE)		 - - - - - - - 23.52% 9.78% 4.57% 10.96%
Cost of Revenue to Revenue		 94.10% 88.72% 89.40% 90.54% 89.81% 89.97% 89.21% 88.71% 86.52% 87.21% 85.95%
SG&A Expenses to Revenue		 4.90% 5.33% 4.72% 4.34% 4.67% 4.85% 4.19% 3.33% 4.05% 4.27% 3.93%
R&D to Revenue		 0.70% 0.65% 0.69% 0.70% 0.81% 0.80% 0.63% 0.54% 0.66% 0.67% 0.60%
Operating Expenses to Revenue		 14.91% 6.09% 5.48% 5.05% 5.49% 7.47% 2.93% 7.27% 8.55% 9.08% 8.44%
Earnings before Interest and Taxes (EBIT)		 -605 281 406 462 286 153 548 253 343 246 517
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 -605 444 611 688 573 469 850 543 643 550 847
Valuation Ratios		 - - - - - - - - - - -
Price to Book Value (P/BV)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 5.04 4.01 2.14 2.73
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 5.03 2.68 3.18
Price to Revenue (P/Rev)		 0.00 0.00 0.00 0.14 0.27 0.32 0.36 0.20 0.37 0.21 0.31
Price to Earnings (P/E)		 0.00 0.00 0.00 4.28 23.53 0.00 8.62 5.44 18.95 26.93 9.51
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 23.37% 4.25% 0.00% 11.60% 18.38% 5.28% 3.71% 10.51%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 1.53 2.04 2.19 1.49 0.00 1.88 1.32 1.59
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 0.50 0.72 0.81 0.75 0.50 0.59 0.45 0.53
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 4.68 8.28 10.33 6.17 7.79 7.17 6.01 5.24
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 6.97 16.59 31.72 9.57 16.71 13.44 13.44 8.59
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 13.11 19.50 45.31 11.58 5.87 17.65 27.35 13.90
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 42.66 9.47 11.87 12.98 11.59 10.67 10.98 9.08
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 159.68 22.50 0.00 0.85 0.00 50.95 155.89
Leverage & Solvency		 - - - - - - - - - - -
Debt to Equity		 0.00 -4.33 -6.67 -18.87 -27.78 -23.67 7.32 2.81 2.60 2.64 2.00
Long-Term Debt to Equity		 0.00 -4.14 -6.34 -18.87 -25.41 -22.76 6.43 2.56 2.54 2.58 1.96
Financial Leverage		 0.00 -3.51 -4.33 -8.54 -20.61 -21.73 26.80 1.46 0.12 2.37 2.12
Leverage Ratio		 0.00 -6.64 -8.59 -17.37 -40.56 -44.52 49.90 9.28 6.61 6.58 5.94
Compound Leverage Factor		 0.00 -1.62 -1.25 -9.55 -13.04 12.11 32.68 5.50 4.47 3.61 4.69
Debt to Total Capital		 0.00% 130.03% 117.64% 105.60% 103.73% 104.41% 87.98% 73.73% 72.22% 72.51% 66.69%
Short-Term Debt to Total Capital		 0.00% 5.64% 5.86% 0.00% 8.83% 4.02% 10.66% 6.60% 1.54% 1.47% 1.34%
Long-Term Debt to Total Capital		 0.00% 124.39% 111.78% 105.60% 94.90% 100.39% 77.31% 67.13% 70.69% 71.04% 65.35%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 18.45% 18.34% 17.36% 14.67% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.47% 0.44% 0.39% 0.48% 0.61% 0.70% 0.73% 0.90% 0.79% 0.65%
Common Equity to Total Capital		 0.00% -30.51% -18.09% -5.99% -22.67% -23.36% -6.03% 10.86% 26.88% 26.69% 32.66%
Debt to EBITDA		 0.00 5.85 4.18 3.58 4.62 6.23 2.83 4.16 3.00 3.49 2.30
Net Debt to EBITDA		 0.00 4.99 3.65 3.30 4.26 5.08 2.64 3.83 2.65 3.23 2.15
Long-Term Debt to EBITDA		 0.00 5.59 3.97 3.58 4.23 5.99 2.49 3.79 2.94 3.42 2.25
Debt to NOPAT		 0.00 -163.03 -12.54 10.01 10.88 27.33 5.32 3.14 7.38 15.87 6.08
Net Debt to NOPAT		 0.00 -139.05 -10.95 9.25 10.03 22.31 4.95 2.89 6.53 14.70 5.71
Long-Term Debt to NOPAT		 0.00 -155.96 -11.92 10.01 9.96 26.27 4.68 2.85 7.23 15.54 5.96
Altman Z-Score		 0.00 0.00 0.00 2.04 1.69 1.62 2.27 1.76 2.33 2.05 2.46
Noncontrolling Interest Sharing Ratio		 0.00% -1.58% -1.94% -3.65% -218.20% -463.43% 497.53% 85.23% 32.06% 3.06% 2.36%
Liquidity Ratios		 - - - - - - - - - - -
Current Ratio		 0.00 1.38 1.26 1.37 1.06 1.35 1.65 0.43 1.28 1.27 1.29
Quick Ratio		 0.00 0.69 0.62 0.72 0.52 0.78 0.48 0.41 0.48 0.43 0.47
Cash Flow Metrics		 - - - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 -1,521 -463 -98 30 215 -846 4,954 -2,909 65 28
Operating Cash Flow to CapEx		 0.00% 24.79% 57.97% 23.83% 164.94% 188.70% 160.81% 126.30% 118.03% 72.88% 148.18%
Free Cash Flow to Firm to Interest Expense		 0.00 -7.69 -1.48 -0.47 0.15 0.00 0.00 48.10 -26.21 0.58 0.26
Operating Cash Flow to Interest Expense		 0.00 0.47 0.62 0.36 2.58 0.00 0.00 3.54 3.89 2.71 4.49
Operating Cash Flow Less CapEx to Interest Expense		 0.00 -1.42 -0.45 -1.16 1.02 0.00 0.00 0.74 0.59 -1.01 1.46
Efficiency Ratios		 - - - - - - - - - - -
Asset Turnover		 0.00 1.25 1.49 1.46 1.45 1.22 1.36 1.62 1.53 1.52 1.68
Accounts Receivable Turnover		 0.00 13.36 14.35 11.08 11.01 11.61 10.97 12.64 14.13 14.42 13.98
Inventory Turnover		 0.00 7.12 8.07 7.71 7.90 7.34 4.28 0.00 0.00 5.38 5.61
Fixed Asset Turnover		 0.00 3.21 3.73 3.49 3.15 2.57 3.07 0.00 0.00 3.04 3.38
Accounts Payable Turnover		 0.00 5.02 5.62 5.22 5.27 4.82 4.66 4.81 4.51 4.70 4.87
Days Sales Outstanding (DSO)		 0.00 27.32 25.44 32.96 33.14 31.45 33.26 28.87 25.83 25.30 26.11
Days Inventory Outstanding (DIO)		 0.00 51.26 45.24 47.32 46.20 49.75 85.34 0.00 0.00 67.84 65.04
Days Payable Outstanding (DPO)		 0.00 72.77 64.89 69.88 69.28 75.72 78.27 75.96 80.94 77.60 74.97
Cash Conversion Cycle (CCC)		 0.00 5.81 5.78 10.40 10.07 5.47 40.32 -47.09 -55.11 15.55 16.19
Capital & Investment Metrics		 - - - - - - - - - - -
Invested Capital		 0.00 1,505 1,765 2,108 2,322 2,214 3,512 -722 2,448 2,504 2,795
Invested Capital Turnover		 0.00 6.63 3.85 3.36 2.99 2.63 2.43 6.12 9.07 2.96 3.19
Increase / (Decrease) in Invested Capital		 0.00 1,505 259 344 214 -108 1,298 -4,234 3,170 56 291
Enterprise Value (EV)		 0.00 0.00 0.00 3,222 4,748 4,844 5,245 4,229 4,610 3,306 4,441
Market Capitalization		 0.00 0.00 0.00 940 1,822 1,929 2,507 1,676 2,880 1,508 2,598
Book Value per Share		 $0.00 $0.00 ($2.92) ($1.04) ($4.26) ($4.74) ($1.18) $2.35 $4.98 $4.81 $6.91
Tangible Book Value per Share		 $0.00 $0.00 ($7.13) ($5.22) ($8.59) ($8.98) ($5.30) ($1.67) $3.97 $3.83 $5.93
Total Capital		 0.00 1,997 2,172 2,331 2,554 2,797 2,739 3,063 2,671 2,645 2,915
Total Debt		 0.00 2,596 2,555 2,462 2,650 2,921 2,410 2,258 1,929 1,918 1,944
Total Long-Term Debt		 0.00 2,484 2,428 2,462 2,424 2,808 2,118 2,056 1,888 1,879 1,905
Net Debt		 0.00 2,214 2,231 2,273 2,442 2,385 2,243 2,081 1,706 1,777 1,824
Capital Expenditures (CapEx)		 0.00 373 332 317 304 216 251 289 366 413 330
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 156 153 261 107 40 1,384 -1,010 254 286 443
Debt-free Net Working Capital (DFNWC)		 0.00 521 476 449 313 577 1,551 -832 477 427 563
Net Working Capital (NWC)		 0.00 408 348 449 88 464 1,259 -1,034 436 388 524
Net Nonoperating Expense (NNE)		 276 -12 -166 28 172 128 156 405 104 61 44
Net Nonoperating Obligations (NNO)		 0.00 2,105 2,148 2,239 2,417 2,337 3,183 -1,527 1,706 1,777 1,824
Total Depreciation and Amortization (D&A)		 0.00 163 205 225 287 316 302 290 300 304 330
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 3.12% 2.43% 4.01% 1.61% 0.68% 19.88% -11.84% 3.25% 3.90% 5.24%
Debt-free Net Working Capital to Revenue		 0.00% 10.44% 7.56% 6.89% 4.72% 9.67% 22.27% -9.76% 6.10% 5.82% 6.66%
Net Working Capital to Revenue		 0.00% 8.18% 5.54% 6.89% 1.32% 7.78% 18.08% -12.12% 5.57% 5.29% 6.20%
Earnings Adjustments		 - - - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 ($0.28) $1.40 $0.43 ($0.15) $1.82 $2.10 $0.85 $0.38 $1.95
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 134.51M 136.00M 137.87M 138.74M 141.00M 143.63M 146.13M 143.52M 135.07M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 ($0.28) $1.37 $0.41 ($0.15) $1.75 $2.06 $0.84 $0.38 $1.92
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 134.51M 136.00M 137.87M 138.74M 147.17M 146.61M 149.24M 143.52M 135.07M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 134.51M 136.00M 137.87M 139.96M 141.68M 144.30M 146.82M 143.52M 135.07M
Normalized Net Operating Profit after Tax (NOPAT)		 30 185 229 246 244 107 453 240 261 190 319
Normalized NOPAT Margin		 0.55% 3.70% 3.64% 3.78% 3.67% 1.79% 6.50% 2.81% 3.34% 2.60% 3.78%
Pre Tax Income Margin		 -11.68% 1.37% 0.94% 3.90% 1.39% -0.70% 5.15% 1.76% 2.96% 1.84% 4.83%
Debt Service Ratios		 - - - - - - - - - - -
EBIT to Interest Expense		 0.00 1.42 1.30 2.22 1.47 0.00 0.00 2.46 3.09 2.22 4.74
NOPAT to Interest Expense		 0.00 -0.08 -0.65 1.18 1.25 0.00 0.00 6.99 2.35 1.09 2.93
EBIT Less CapEx to Interest Expense		 0.00 -0.47 0.24 0.70 -0.09 0.00 0.00 -0.35 -0.21 -1.50 1.72
NOPAT Less CapEx to Interest Expense		 0.00 -1.97 -1.71 -0.34 -0.31 0.00 0.00 4.19 -0.94 -2.63 -0.10
Payout Ratios		 - - - - - - - - - - -
Dividend Payout Ratio		 0.00% -50.00% 0.00% 0.00% 6.25% 0.00% 0.76% 0.63% 1.91% 8.33% 2.55%
Augmented Payout Ratio		 0.00% -50.00% 0.00% 0.00% 6.25% 0.00% 0.76% 0.63% 1.91% 140.00% 44.36%

Quarterly Metrics And Ratios for Constellium

This table displays calculated financial ratios and metrics derived from Constellium's official financial filings.

Metric Q1 2024 Q2 2024 Q3 2024 Q4 2024 Q1 2025 Q2 2025 Q3 2025 Q4 2025 Q1 2026
Period end date 3/31/2024 6/30/2024 9/30/2024 12/31/2024 3/31/2025 6/30/2025 9/30/2025 12/31/2025 3/31/2026
DEI Shares Outstanding		 - - - - - - - - 136,150,450.00
DEI Adjusted Shares Outstanding		 - - - - - - - - 136,150,450.00
DEI Earnings Per Adjusted Shares Outstanding		 - - - - - - - - 1.46
Growth Metrics		 - - - - - - - - -
Revenue Growth		 0.00% 0.00% 0.00% 0.00% 5.27% 8.85% 20.20% 27.89% 24.36%
EBITDA Growth		 0.00% 0.00% 0.00% 0.00% 26.52% -18.54% 88.10% 160.38% 129.34%
EBIT Growth		 0.00% 0.00% 0.00% 0.00% 56.14% -34.11% 206.00% 555.17% 237.08%
NOPAT Growth		 0.00% 0.00% 0.00% 0.00% 4.75% -39.37% 324.25% 463.44% 183.92%
Net Income Growth		 0.00% 0.00% 0.00% 0.00% 72.73% -53.25% 1,000.00% 340.43% 415.79%
EPS Growth		 0.00% 0.00% 0.00% 0.00% 85.71% -50.98% 1,140.00% 346.88% 446.15%
Operating Cash Flow Growth		 0.00% 0.00% 0.00% 0.00% 56.76% -17.39% 52.31% 257.38% 25.86%
Free Cash Flow Firm Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 91.77%
Invested Capital Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 11.62% 14.36%
Revenue Q/Q Growth		 0.00% 2.77% -6.73% -4.50% 0.00% 6.27% 3.00% 1.62% 11.81%
EBITDA Q/Q Growth		 0.00% 55.30% -38.54% -15.87% 0.00% 0.00% 41.92% 16.46% 38.77%
EBIT Q/Q Growth		 0.00% 126.32% -61.24% -42.00% 0.00% -4.49% 80.00% 24.18% 57.89%
NOPAT Q/Q Growth		 0.00% 56.15% -74.51% -7.28% 0.00% -9.62% 78.39% 23.13% 43.01%
Net Income Q/Q Growth		 0.00% 250.00% -89.61% -687.50% 0.00% -5.26% 144.44% 28.41% 73.45%
EPS Q/Q Growth		 0.00% 264.29% -90.20% -740.00% 0.00% -3.85% 148.00% 27.42% 79.75%
Operating Cash Flow Q/Q Growth		 0.00% 272.97% -52.90% -6.15% 0.00% 96.55% -13.16% 120.20% -66.51%
Free Cash Flow Firm Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% -4.25% -0.76% 93.36% -18.01%
Invested Capital Q/Q Growth		 0.00% 0.00% 0.00% 0.00% 0.00% 3.94% 2.27% 1.53% 5.98%
Profitability Metrics		 - - - - - - - - -
Gross Margin		 13.03% 14.49% 11.38% 12.09% 13.29% 12.51% 14.50% 15.77% 17.07%
EBITDA Margin		 7.02% 10.61% 6.99% 6.16% 8.44% 7.94% 10.94% 12.54% 15.56%
Operating Margin		 3.99% 6.00% 2.89% 1.69% 4.75% 3.85% 6.14% 7.54% 9.22%
EBIT Margin		 3.03% 6.68% 2.77% 1.69% 4.50% 4.04% 7.06% 8.63% 12.19%
Profit (Net Income) Margin		 1.17% 3.99% 0.44% -2.73% 1.92% 1.71% 4.06% 5.13% 7.96%
Tax Burden Percent		 73.33% 74.04% 42.11% 261.11% 61.29% 64.29% 69.84% 68.90% 72.06%
Interest Burden Percent		 52.63% 80.62% 38.00% -62.07% 69.66% 65.88% 82.35% 86.32% 90.67%
Effective Tax Rate		 26.67% 25.96% 57.89% 0.00% 38.71% 35.71% 30.16% 31.10% 27.94%
Return on Invested Capital (ROIC)		 0.00% 0.00% 0.00% 3.46% 16.71% 13.99% 24.83% 16.57% 21.38%
ROIC Less NNEP Spread (ROIC-NNEP)		 0.00% 0.00% 0.00% -0.33% 14.56% 12.29% 24.31% 16.50% 23.16%
Return on Net Nonoperating Assets (RNNOA)		 0.00% 0.00% 0.00% -0.81% 34.74% 29.12% 53.24% 34.98% 44.62%
Return on Equity (ROE)		 0.00% 0.00% 0.00% 2.64% 51.45% 43.11% 78.07% 51.55% 66.00%
Cash Return on Invested Capital (CROIC)		 0.00% 0.00% 0.00% 2.59% 0.00% 0.00% 0.00% 1.08% 1.92%
Operating Return on Assets (OROA)		 0.00% 0.00% 0.00% 2.56% 6.47% 5.73% 10.47% 14.46% 19.77%
Return on Assets (ROA)		 0.00% 0.00% 0.00% -4.14% 2.76% 2.43% 6.02% 8.60% 12.92%
Return on Common Equity (ROCE)		 0.00% 0.00% 0.00% 2.56% 50.11% 42.09% 76.44% 50.34% 64.85%
Return on Equity Simple (ROE_SIMPLE)		 0.00% 0.00% 0.00% 0.00% 10.20% 0.00% 0.00% 0.00% 0.00%
Net Operating Profit after Tax (NOPAT)		 55 86 22 20 58 52 93 114 164
NOPAT Margin		 2.93% 4.45% 1.22% 1.18% 2.91% 2.48% 4.29% 5.20% 6.65%
Net Nonoperating Expense Percent (NNEP)		 0.00% 0.00% 0.00% 3.79% 2.15% 1.70% 0.52% 0.08% -1.77%
Return On Investment Capital (ROIC_SIMPLE)		 - - - 0.77% 2.13% 1.84% 3.23% 3.92% 5.27%
Cost of Revenue to Revenue		 86.97% 85.51% 88.62% 87.91% 86.71% 87.49% 85.50% 84.23% 82.93%
SG&A Expenses to Revenue		 4.26% 3.88% 3.66% 5.35% 3.94% 4.18% 3.92% 3.68% 3.94%
R&D to Revenue		 0.80% 0.67% 0.61% 0.58% 0.66% 0.57% 0.55% 0.64% 0.53%
Operating Expenses to Revenue		 9.04% 8.49% 8.49% 10.40% 8.54% 8.65% 8.36% 8.22% 7.84%
Earnings before Interest and Taxes (EBIT)		 57 129 50 29 89 85 153 190 300
Earnings before Interest, Taxes, Depreciation and Amortization (EBITDA)		 132 205 126 106 167 167 237 276 383
Valuation Ratios		 - - - - - - - - -
Price to Book Value (P/BV)		 0.00 0.00 0.00 2.14 1.94 2.44 2.46 2.73 2.97
Price to Tangible Book Value (P/TBV)		 0.00 0.00 0.00 2.68 2.39 2.97 2.93 3.18 3.36
Price to Revenue (P/Rev)		 0.00 0.00 0.00 0.21 0.19 0.25 0.26 0.31 0.37
Price to Earnings (P/E)		 0.00 0.00 0.00 26.93 20.11 59.40 18.37 9.51 7.63
Dividend Yield		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Earnings Yield		 0.00% 0.00% 0.00% 3.71% 4.97% 1.68% 5.44% 10.51% 13.10%
Enterprise Value to Invested Capital (EV/IC)		 0.00 0.00 0.00 1.32 1.27 1.42 1.45 1.59 1.74
Enterprise Value to Revenue (EV/Rev)		 0.00 0.00 0.00 0.45 0.44 0.50 0.50 0.53 0.58
Enterprise Value to EBITDA (EV/EBITDA)		 0.00 0.00 0.00 5.74 5.63 6.97 6.06 5.24 4.86
Enterprise Value to EBIT (EV/EBIT)		 0.00 0.00 0.00 12.15 11.85 16.29 11.82 8.59 7.09
Enterprise Value to NOPAT (EV/NOPAT)		 0.00 0.00 0.00 27.35 24.87 50.64 23.23 13.90 12.14
Enterprise Value to Operating Cash Flow (EV/OCF)		 0.00 0.00 0.00 10.98 10.23 12.79 12.00 9.08 10.24
Enterprise Value to Free Cash Flow (EV/FCFF)		 0.00 0.00 0.00 0.00 0.00 0.00 0.00 155.89 96.88
Leverage & Solvency		 - - - - - - - - -
Debt to Equity		 0.00 0.00 0.00 2.64 2.54 2.54 2.33 2.00 1.74
Long-Term Debt to Equity		 0.00 0.00 0.00 2.58 2.49 2.47 2.29 1.96 1.71
Financial Leverage		 0.00 0.00 0.00 2.44 2.39 2.37 2.19 2.12 1.93
Leverage Ratio		 0.00 0.00 0.00 6.58 6.76 6.72 6.23 5.94 5.81
Compound Leverage Factor		 0.00 0.00 0.00 -4.08 4.71 4.43 5.13 5.13 5.26
Debt to Total Capital		 0.00% 0.00% 0.00% 72.51% 71.75% 71.72% 69.98% 66.69% 63.54%
Short-Term Debt to Total Capital		 0.00% 0.00% 0.00% 1.47% 1.29% 1.91% 1.32% 1.34% 1.13%
Long-Term Debt to Total Capital		 0.00% 0.00% 0.00% 71.04% 70.46% 69.81% 68.66% 65.35% 62.42%
Preferred Equity to Total Capital		 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00% 0.00%
Noncontrolling Interests to Total Capital		 0.00% 0.00% 0.00% 0.79% 0.74% 0.67% 0.63% 0.65% 0.42%
Common Equity to Total Capital		 0.00% 0.00% 0.00% 26.69% 27.51% 27.61% 29.39% 32.66% 36.04%
Debt to EBITDA		 0.00 0.00 0.00 3.33 3.32 3.70 3.06 2.30 1.86
Net Debt to EBITDA		 0.00 0.00 0.00 3.09 3.12 3.46 2.87 2.15 1.72
Long-Term Debt to EBITDA		 0.00 0.00 0.00 3.26 3.26 3.61 3.00 2.25 1.82
Debt to NOPAT		 0.00 0.00 0.00 15.87 14.67 26.91 11.73 6.08 4.64
Net Debt to NOPAT		 0.00 0.00 0.00 14.70 13.78 25.14 11.02 5.71 4.30
Long-Term Debt to NOPAT		 0.00 0.00 0.00 15.54 14.41 26.19 11.51 5.96 4.56
Altman Z-Score		 0.00 0.00 0.00 1.92 1.79 1.82 1.97 2.26 2.42
Noncontrolling Interest Sharing Ratio		 0.00% 0.00% 0.00% 3.06% 2.61% 2.38% 2.09% 2.36% 1.74%
Liquidity Ratios		 - - - - - - - - -
Current Ratio		 0.00 0.00 0.00 1.27 1.24 1.23 1.28 1.29 1.39
Quick Ratio		 0.00 0.00 0.00 0.43 0.52 0.50 0.51 0.47 0.54
Cash Flow Metrics		 - - - - - - - - -
Free Cash Flow to Firm (FCFF)		 0.00 0.00 0.00 0.00 -2,532 -2,640 -2,660 -177 -208
Operating Cash Flow to CapEx		 50.00% 164.29% 62.50% 40.40% 84.06% 148.05% 132.00% 200.00% 101.39%
Free Cash Flow to Firm to Interest Expense		 0.00 0.00 0.00 0.00 -93.79 -91.03 -98.52 -6.79 -7.44
Operating Cash Flow to Interest Expense		 1.37 5.52 2.10 2.18 2.15 3.93 3.67 8.38 2.61
Operating Cash Flow Less CapEx to Interest Expense		 -1.37 2.16 -1.26 -3.21 -0.41 1.28 0.89 4.19 0.04
Efficiency Ratios		 - - - - - - - - -
Asset Turnover		 0.00 0.00 0.00 1.52 1.44 1.42 1.48 1.68 1.62
Accounts Receivable Turnover		 0.00 0.00 0.00 14.42 9.09 9.45 9.73 13.98 9.80
Inventory Turnover		 0.00 0.00 0.00 5.38 5.07 5.02 5.07 5.61 5.15
Fixed Asset Turnover		 0.00 0.00 0.00 3.04 3.03 2.97 3.10 3.38 3.59
Accounts Payable Turnover		 0.00 0.00 0.00 4.70 3.89 3.88 4.05 4.87 4.17
Days Sales Outstanding (DSO)		 0.00 0.00 0.00 25.30 40.16 38.64 37.51 26.11 37.25
Days Inventory Outstanding (DIO)		 0.00 0.00 0.00 67.84 72.01 72.72 72.04 65.04 70.94
Days Payable Outstanding (DPO)		 0.00 0.00 0.00 77.60 93.81 94.02 90.23 74.97 87.51
Cash Conversion Cycle (CCC)		 0.00 0.00 0.00 15.55 18.36 17.34 19.32 16.19 20.68
Capital & Investment Metrics		 - - - - - - - - -
Invested Capital		 0.00 0.00 0.00 2,504 2,590 2,692 2,753 2,795 2,962
Invested Capital Turnover		 0.00 0.00 0.00 2.93 5.74 5.65 5.79 3.19 3.22
Increase / (Decrease) in Invested Capital		 0.00 0.00 0.00 0.00 2,590 2,692 2,753 291 372
Enterprise Value (EV)		 0.00 0.00 0.00 3,306 3,293 3,813 3,984 4,441 5,163
Market Capitalization		 3,246 2,768 2,387 1,508 1,448 1,901 2,076 2,598 3,320
Book Value per Share		 $0.00 $0.00 $0.00 $4.81 $5.19 $5.46 $6.06 $6.91 $8.28
Tangible Book Value per Share		 $0.00 $0.00 $0.00 $3.83 $4.22 $4.48 $5.07 $5.93 $7.31
Total Capital		 0.00 0.00 0.00 2,645 2,708 2,825 2,875 2,915 3,105
Total Debt		 0.00 0.00 0.00 1,918 1,943 2,026 2,012 1,944 1,973
Total Long-Term Debt		 0.00 0.00 0.00 1,879 1,908 1,972 1,974 1,905 1,938
Net Debt		 0.00 0.00 0.00 1,777 1,825 1,893 1,890 1,824 1,830
Capital Expenditures (CapEx)		 74 84 104 151 69 77 75 109 72
Debt-free, Cash-free Net Working Capital (DFCFNWC)		 0.00 0.00 0.00 286 345 360 427 443 725
Debt-free Net Working Capital (DFNWC)		 0.00 0.00 0.00 427 463 493 549 563 868
Net Working Capital (NWC)		 0.00 0.00 0.00 388 428 439 511 524 833
Net Nonoperating Expense (NNE)		 33 8.88 14 67 20 16 4.89 1.38 -32
Net Nonoperating Obligations (NNO)		 0.00 0.00 0.00 1,777 1,825 1,893 1,890 1,824 1,830
Total Depreciation and Amortization (D&A)		 75 76 76 77 78 82 84 86 83
Debt-free, Cash-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 3.90% 4.64% 4.73% 5.36% 5.24% 8.12%
Debt-free Net Working Capital to Revenue		 0.00% 0.00% 0.00% 5.82% 6.23% 6.48% 6.89% 6.66% 9.72%
Net Working Capital to Revenue		 0.00% 0.00% 0.00% 5.29% 5.76% 5.77% 6.41% 6.20% 9.33%
Earnings Adjustments		 - - - - - - - - -
Adjusted Basic Earnings per Share		 $0.00 $0.00 $0.00 ($0.33) $0.26 $0.25 $0.63 $0.81 $1.47
Adjusted Weighted Average Basic Shares Outstanding		 0.00 0.00 0.00 143.52M 142.92M 139.54M 137.80M 135.07M 136.15M
Adjusted Diluted Earnings per Share		 $0.00 $0.00 $0.00 ($0.32) $0.26 $0.25 $0.62 $0.79 $1.42
Adjusted Weighted Average Diluted Shares Outstanding		 0.00 0.00 0.00 143.52M 142.92M 139.54M 137.80M 135.07M 136.15M
Adjusted Basic & Diluted Earnings per Share		 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00 $0.00
Adjusted Weighted Average Basic & Diluted Shares Outstanding		 0.00 0.00 0.00 143.52M 142.92M 139.54M 137.80M 135.07M 136.15M
Normalized Net Operating Profit after Tax (NOPAT)		 55 86 36 20 58 52 93 114 164
Normalized NOPAT Margin		 2.93% 4.45% 2.02% 1.18% 2.91% 2.48% 4.29% 5.20% 6.65%
Pre Tax Income Margin		 1.60% 5.38% 1.05% -1.05% 3.13% 2.66% 5.82% 7.45% 11.05%
Debt Service Ratios		 - - - - - - - - -
EBIT to Interest Expense		 2.11 5.16 1.61 1.04 3.30 2.93 5.67 7.31 10.71
NOPAT to Interest Expense		 2.04 3.44 0.71 0.73 2.13 1.80 3.44 4.40 5.84
EBIT Less CapEx to Interest Expense		 -0.63 1.80 -1.74 -4.36 0.74 0.28 2.89 3.12 8.14
NOPAT Less CapEx to Interest Expense		 -0.70 0.08 -2.65 -4.67 -0.42 -0.86 0.66 0.21 3.27
Payout Ratios		 - - - - - - - - -
Dividend Payout Ratio		 0.00% 0.00% 0.00% 8.33% 7.89% 17.14% 6.96% 2.55% 2.08%
Augmented Payout Ratio		 0.00% 0.00% 0.00% 140.00% 122.37% 274.29% 88.70% 44.36% 31.64%

Financials Breakdown Chart

Key Financial Trends

Constellium (CSTM) shows a clear improvement in profitability and cash generation in 2025 versus 2024, supported by rising revenue, improving margins in several quarters, and stronger operating cash flow. Below are the standout trends based on the last four quarters of 2025 and the four quarters of 2024.

  • Revenue moved higher year-over-year in every 2025 quarter. 2025 Q1 revenue was about $1.98B, Q2 about $2.10B, Q3 about $2.17B, and Q4 about $2.20B, versus 2024 Q1–Q4 revenues of roughly $1.88B, $1.93B, $1.80B, and $1.72B respectively.
  • Gross profit and gross margin improved meaningfully in 2025. For example, Q4 2025 gross margin was about 15.8% (347M gross profit on 2.201B revenue), up from 12.1% in Q4 2024. Q3 2025 margin was about 14.5%, compared with roughly 11.4% in Q3 2024. Q1 2025 and Q2 2025 also show favorable margin evolution versus their 2024 comparables.
  • Operating income expanded notably in 2025, led by a strong Q4. Q4 2025 operating income was about $166M versus $29M in Q4 2024; Q3 2025 was about $133M vs $52M in Q3 2024; Q1 and Q3 2025 also show improvement versus their 2024 levels.
  • Net income attributable to common shareholders turned positive in 2025, with earnings per share turning positive as well. Q4 2025 net income to common shareholders was about $112M with Basic EPS around $0.81 and Diluted EPS about $0.79, up from a 2024 period where earnings were negative in several quarters.
  • Net cash from continuing operating activities rose markedly in 2025. Q4 2025 net cash from continuing operating activities was about $218M, well above the roughly $61M seen in Q4 2024. Q3 2025 and Q2 2025 also show solid operating cash flow generation.
  • Free cash flow potential improved. With capex (PPE purchases) running lower in late 2024 and 2025 (e.g., Q4 2025 PPE about $109M vs Q4 2024 about $151M), cash flow after capital expenditures has improved, contributing to a more favorable cash profile.
  • Equity base strengthened. Total equity (including noncontrolling interests) rose from about $765M at end-2024 to about $863M by Q3-2025, signaling a stronger capital base to support operations and growth.
  • Capex discipline appears favorable. PPE purchases declined across 2025 (e.g., Q1–Q4 2025 figures generally lower than their 2024 year-ago levels), suggesting lower near-term investment intensity while cash flow remains strong.
  • Balance sheet stability with solid asset base. Total assets hovered in the mid-$5B range (roughly $5.16B–$5.38B across 2024–2025), and liability levels stayed substantial but manageable relative to assets, supporting ongoing operations.
  • Gross margin in Q2 2025 was a bit softer year over year (about 12.5% in Q2 2025 vs roughly 14.5% in Q2 2024), indicating some quarterly volatility in profitability that may reflect mix or input costs. Overall 2025 margins remained higher than in 2024, but this quarter stands out as a softer point.
  • Some quarters show lighter or more mixed operating leverage. For example, Q2 2025 operating income fell versus Q2 2024 (81M vs 116M), even as other quarters strengthened. This suggests ongoing sensitivity to product mix and cost structure on a quarterly basis.
  • Financing cash flows have been negative in several quarters, reflecting ongoing debt and financing activity. For instance, Q4 2025 net cash from financing activities was negative (outflows), contributing to the quarterly net change in cash. This is a normal pattern for a capital-intensive company but is worth watching if leverage or debt costs rise.
  • Inventory and working capital levels remain sizable. Inventories net (as of 2025 Q3) were high relative to current assets, which can tie up working capital and impact cash generation if demand softens.
  • Short-term liquidity metrics are not shown in full here, but current liabilities remain substantial (e.g., current liabilities around $1.8B–$1.9B in mid-2025), warranting attention to working capital management in periods of demand volatility.
  • Q2 2025 gross margin softness and quarterly mix pressure. Despite an overall positive trend, Q2 2025 gross margin slipped versus Q2 2024, suggesting some quarterly profitability pressure from product mix or input costs.
  • Near-term cash movements can be volatile. Net change in cash for some 2025 quarters was negative (e.g., Q3 2025 net change in cash around -$11M; Q4 2025 around -$3M), driven by financing activities and capex timing.
  • Financing outflows persisted in 2025, contributing to negative quarterly cash flow from financing activities. This could impact liquidity if not offset by operating cash flow gains or reductions in capex.
05/22/26 04:35 AM ETAI Generated. May Contain Errors.

Constellium Financials - Frequently Asked Questions

According to the most recent income statement we have on file, Constellium's financial year ends in December. Their financial year 2025 ended on December 31, 2025.

Constellium's net income appears to be on an upward trend, with a most recent value of $275 million in 2025, falling from -$599.77 million in 2015. The previous period was $60 million in 2024. View Constellium's forecast to see where analysts expect Constellium to go next.

Constellium's total operating income in 2025 was $474 million, based on the following breakdown:
  • Total Gross Profit: $1.19 billion
  • Total Operating Expenses: $713 million

Over the last 10 years, Constellium's total revenue changed from $5.43 billion in 2015 to $8.45 billion in 2025, a change of 55.6%.

Constellium's total liabilities were at $4.38 billion at the end of 2025, a 9.4% increase from 2024, and a 4.4% decrease since 2016.

In the past 9 years, Constellium's cash and equivalents has ranged from $120 million in 2025 to $536.28 million in 2020, and is currently $120 million as of their latest financial filing in 2025.

Over the last 10 years, Constellium's book value per share changed from 0.00 in 2015 to 6.91 in 2025, a change of 690.9%.


Related Companies

Financial statements for NYSE:CSTM last updated on 5/3/2026 by MarketBeat.com Staff. New filings and market data are monitored continuously.
From Our Partners
System failure: The strongest leverage for gold…
$9 trillion in U.S. debt must be refinanced in 2026 - at current rates - while the largest foreign buyers of T...
Golden Portfolio | Sponsoredtc pixel
I had never heard of this 1888 account
An investment account dating back to 1888 has quietly delivered average annual returns of 29% over the last 25...
The Oxford Club | Sponsoredtc pixel
"Computers are about to become obsolete" - George Gilder. Here’s why.
George Gilder predicted the iPhone 16 years early, called Netflix a decade before it dominated streaming, and ...
Eagle Publishing | Sponsoredtc pixel
SpaceX controls two-thirds of all satellites - and it is about to go public
SpaceX is targeting an IPO on June 11th, with trading set to begin June 12th and the roadshow kicking off June...
NXT Wave Research | Sponsoredtc pixel
Hey, it's Jon Najarian. The SpaceX IPO is right around the corner. But I discovered Elon may have something BIGGER planned. Check this out before June 9th...
After being invited to the SpaceX launch headquarters in Cape Canaveral from one of Elon's top lobbyists… Hall...
Banyan Hill Publishing | Sponsoredtc pixel
How to Profit from Elon’s AI lab before it goes public
Elon Musk's AI lab has partnered with the Department of Defense, Oracle, and Palantir - and he just filed conf...
InvestorPlace | Sponsoredtc pixel
Your $29.97 book is free today
Why Some Traders Skip Stocks Entirely You don't need a big account to trade options. In fact, options ca...
Profits Run | Sponsoredtc pixel
A letter from Shannon Stansberry
Porter Stansberry nearly canceled the entire project. When he first saw the claimed returns - only one down ye...
Porter & Company | Sponsoredtc pixel